中华医学杂志（英文版）2013，Vol.126Issue(2)：385-386,2.DOI:10.3760/cma.j.issn.0366-6999.20113067
Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma
HUANG Yong-hui 1CHEN Wei 1LI Jia-ping 1CHEN Bin 1YANG Jian-yong1
作者信息
- 1. Department of Interventional Radiology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China
- 折叠
摘要
关键词
hepatocellular carcinoma/ progression-free survival/ sorafenib/ transarterial chemoembolizationKey words
hepatocellular carcinoma/ progression-free survival/ sorafenib/ transarterial chemoembolization引用本文复制引用
HUANG Yong-hui,CHEN Wei,LI Jia-ping,CHEN Bin,YANG Jian-yong..Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma[J].中华医学杂志（英文版）,2013,126(2):385-386,2.
